Phyto-oestrogens

Adams, N.R. (1998). Clover phyto-oestrogens in sheep in Western Austraba. Pure and Applied Chemistry 1855-1862. [Pg.337]

CASSIDY A, FAUGHAN M (2000) Phyto-oestrogens through the life cycle. Froc Nutr Soc. 59 489-96. [Pg.81]

ADLERCREUTZ H, HONJO H, HIGASHI A, FOTSIS T, HAMALAINEN E, HASEGAWA T and OKADA H (1991) Urinary excretion of lignans and isoflavonoid phyto-oestrogens in Japanese men and women consuming traditional Japanese diet. Am J Clin Nutr. 54 (6) 1093-100. [Pg.211]

ADLERCREUTZ H, MARKKANEN H and WATANABE s (1993) Plasma Concentrations of phyto-oestrogens in Japanese men. Lancet 342 (8881) 1209-10. [Pg.211]

HUGGETT A c, PRIDMORE s, MALNOE A, HASCHKE F and OFFORD E A (1997) Phyto-oestrogens in soy based infant formula. Lancet. 350 (9080) 815-16. [Pg.215]

SETCHELL KDR, ZIMMER-NECHEMIAS L, CAI J and HEUBI J E (1997) Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet. 350 (9070) 27-21. [Pg.219]

WISEMAN H (1999) The bioavailability of non-nutrient plant factors dietary flavonoids and phyto-oestrogens. Proc Nutr Soc. 58 (1) 139-46. [Pg.221]

ADLERCREUTZ H, MAZUR w (1997) Phyto-oestrogens and Western diseases, Ann Med, 29, 95-120. [Pg.294]

Soy protein (i) Osteoporosis (ii) Breast and ovarian cancer (i) Presence of phyto-oestrogens which inhibit damage to DNA (ii) Phyto-oestrogens compete with oestrogen for receptors on breast and ovarian cells... [Pg.359]

Barnes, S., Phyto-oestrogens and osteoporosis what is a safe dose Br. J. Nutr., 89 (Suppl. 1), SlOl, 2003. [Pg.355]

Mazur, W.M., Uehara, M., Wahala, K., and Adlercreutz, H., Phyto-oestrogen content of berries, and plasma concentrations and urinary excretion of enterolactone after a single strawberry-meal in human subjects, Br. J. Nutr., 83, 381, 2000. [Pg.358]

Shutt, D.A. and Cox, R.I., Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro, J. Endocrinol, 52, 299, 1972. [Pg.366]

Ritchie MR, Morton M8, Deighton N, Blake A, Cummings JH. Plasma and urinary phyto-oestrogens as biomarkers of intake validity by duplicate diet analysis. Br. J. Nutr. 91, 447 57, 2004. [Pg.388]

Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 3, 32-40, 2002. [Pg.390]

Magee PJ, Rowland IR. Phyto-oestrogens, their mechanism of action current evidence for a role in breast and prostate cancer. Br. J. Nutr. 91, 513-531, 2004. [Pg.390]

Ingram D, Sanders K, Kolybaba M, Lopez D. Case control study of phyto-oestrogens and breast cancer. Lancet 350, 990-994, 1997. [Pg.390]

Sathyamoorthy N, Wang TT. Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur. J. Cancer 33, 2384-2389, 1997. [Pg.392]

Duncan AM, Phipps WR, Kurzer MS. 2003. Phyto-oestrogens. Best Pract Res Clin Endocrinol Metab 17 253-271. [Pg.232]

Heald CL, Ritchie MR, Bolton-Smith C, Morton MS, Alexander FE. 2007. Phyto-oestrogens and risk of prostate cancer in Scottish men. Br J Nutr 98 388-396. [Pg.233]

Bingham SA, Atkinson C, Liggins J, Bluck L, Coward A. 1998. Phyto-oestrogens Where are we now Br J Nutr 79 393-406. [Pg.245]

Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A. 2003. Bioavailability of phyto-oestrogens. Br J Nutr 89 S45-S58. [Pg.247]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...